慢性肾脏病与突发听力损失风险
研究基于1993年听力损失流行病学研究,纳入1843名48至80岁基线无听力损失者,随访15年,评估基线估算肾小球滤过率(eGFRCr)及eGFRCr下降与突发听力损失的关联。结果显示,较低基线eGFRCr及eGFRCr下降均与突发听力损失风险无显著关联。
要点
- 在15676人年随访中,共发生802例突发听力损失。
- 较低基线eGFRCr与突发听力损失风险无统计学显著关联。
- eGFRCr下降与言语频率突发听力损失亦无关联。
核心结论
- 总体而言,基于血清肌酐方程的eGFRCr或eGFRCr下降与突发听力损失风险无显著关联。
研究设计与样本
- 研究纳入1843名48至80岁基线无听力损失的个体,随访15年,随访期间进行听力测试和肌酐评估。
主要发现
- 在15676人年随访中,共发生802例突发听力损失。
- 较低基线eGFRCr与突发听力损失风险无统计学显著关联。
- eGFRCr下降与言语频率突发听力损失亦无关联。
关键数值与推荐
- 突发听力损失定义为任一侧耳0.5、1、2、4 kHz纯音平均听阈(PTA0.5,1,2,4)大于25分贝听力损失。
- 使用Cox比例风险回归评估风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is a strikingly high prevalence of sensorineural hearing loss among patients with chronic kidney disease, with estimates ranging from 36% to 77%; however, longitudinal data are limited. We assessed whether lower baseline estimated glomerular filtration rate calculated using creatinine (eGFRCr ), as well as decline in eGFRCr over time, were associated with incident hearing loss. METHODS: Serum creatinine was measured in 1,843 individuals aged 48 to 80 years without hearing loss at the start of the Epidemiology of Hearing Loss Study in 1993. Follow-up creatinine assessments were conducted at 5 (n = 1,526) and 10 (n = 1,095) years. Hearing tests were conducted at baseline and at 5-, 10-, and 15-year follow-up visits. The risk of hearing loss was assessed as a function of baseline eGFRCr as well as a function of a 20% decline in eGFRCr between baseline and 5 years and between 5 and 10 years. Cox proportional hazards regression was used to examine the risk of incident speech-frequency hearing loss, defined as pure tone average (PTA) > 25 decibels hearing loss for thresholds at 0.5, 1, 2, and 4 kHz (PTA0.5,1,2,4 ) in either ear. RESULTS: During 15,676 person-years of follow up, there were 802 cases of incident hearing loss. There was no statistically significant association between lower baseline eGFRCr and risk of incident hearing loss. Decline in eGFRCr was also not associated with incident hearing loss at speech frequencies. CONCLUSION: Overall, there was no significant association between eGFRCr or decline in eGFRCr using the serum creatinine-based equation and risk of incident hearing loss. LEVEL OF EVIDENCE: 2 Laryngoscope, 130:E213-E219, 2020.
引用
- Gupta S, Curhan SG, Cruickshanks KJ, et al. Chronic kidney disease and the risk of incident hearing loss. Laryngoscope. 2019. PMID: 31135964. doi:10.1002/lary.28088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。